High-intensity drinking is worse than binge drinking. But what exactly does it mean? High intensity is defined as consuming an excessive number of drinks in one session: eight or more for women and ten or more for men.

While binge drinking is characterized by having four or five drinks within two hours.

This distinction emerged as researchers noticed that many of the severe consequences associated with binge drinking—like blackouts and alcohol poisoning—were linked to much higher levels of alcohol intake.

Who are the most at risk?

Heavy drinking habits, formerly associated with youth, are changing. Recent studies show that, while high-intensity drinking has decreased among young adults, it is still common among those in their late twenties. Almost one out of every eight people aged 27 to 28 consume 10 or more drinks every session.

Middle-aged individuals are drinking more heavily. It is more prominent in males over 30 and women aged 18 to 64.

The trend can be seen where the middle-aged uses alcohol as a tool to cope with the day-to-day life, whereas for youth, it is to have fun and to explore the adult life.

Risks and Consequences

High-intensity drinking carries a greater risk than regular binge drinking. It is because when you consume such large volumes of alcohol in such a short period of time, it can boost blood alcohol concentration (BAC) to dangerous levels, usually exceeding 0.2%, as opposed to 0.08% for ordinary binge drinking.

This high BAC level increases the risk of disastrous effects, including:

• Injuries and Accidents
• Alcohol Poisoning
• Blackouts
• Hospitalizations

ALSO READ: Is Your Social Drinking Hurting Your Liver? A Scottish Woman Opens About Developing Chronic Liver Disease

Moreover, repeated high-intensity drinking significantly raises the risk of developing alcohol use disorder and contributes to broader societal harms such as relationship issues, property damage, and physical assaults.

Why is there a change in drinking patterns?

The reason why one opts for high-intensity drinking patterns varies by age. For youth, it is mostly peer pressure and seeking fun. However it does have its own downsides.

For middle-aged and older adults, stress, life pressures, and emotional coping mechanisms are more common drivers. However, studies have shown that alcohol does not help you cope with stress. These motivations highlight the evolving role of alcohol as a tool for both celebration and self-medication, depending on the stage of life.

The Need for Greater Awareness

The rise of high-intensity drinking underscores the importance of addressing its unique dangers. While binge drinking is risky, consuming eight or more drinks exponentially increases the likelihood of harm. Experts emphasize that the “dose makes the poison,” and this extreme form of alcohol use deserves heightened attention.

By understanding the motivations and risks associated with high-intensity drinking, individuals can make informed decisions and seek support if needed, particularly during festive seasons that often encourage overindulgence.

A new botulism outbreak in the United States linked to the now-recalled Nara Organics Whole Milk Organic powdered infant formula has led to hospitalization of at least three infants in three states, according to a notice from the Centers for Disease Control and Prevention (CDC).

The affected infants, aged between 2 and 5 months, are from California, Pennsylvania, and Washington state. All three have been hospitalized and are receiving treatment for infection caused by the bacterium Clostridium botulinum.

The CDC noted that on June 13, Nara Organics recalled all Nara Organics Whole Milk Organic Infant Formula products, including all lot numbers and both can sizes. The products were sold online and at major retailers nationwide.

“Testing of opened cans of Nara Organics brand formula and unopened Nara Organics product samples is underway, and results are expected in the coming weeks,” the CDC said.

This is the second recent outbreak of infant botulism linked to powdered formula. Earlier this year, investigators from the California Department of Public Health, working with federal officials and other state health departments, identified 51 suspected or confirmed cases of infant botulism across 19 states between March 2022 and December 2025. Those infants had consumed ByHeart infant formula.

What Parents And Caregivers Should Do

Also read: Why Sleeping Pill Addiction Is Common Among Football Players

The CDC has urged parents and caregivers to immediately stop using any Nara Organics Whole Milk Organic Infant Formula.

If you have unopened cans of the recalled formula, throw them away or return them. Parents should also wash any items and surfaces that may have come into contact with the formula with hot, soapy water or in the dishwasher.

Seek immediate medical attention if your infant consumed the recalled formula and develops any of the following symptoms:

• Poor feeding
• Loss of head control
• Difficulty swallowing
• Decreased facial expression

Symptoms of infant botulism can take several weeks to appear. Parents whose infants consumed the recalled formula should monitor them for symptoms for up to one month after their last exposure.

What Is Botulism?

Read More: Introducing Eggs Before Age One May Lower Allergy Risk by 17%: Study

Botulism is a rare but serious illness caused by a toxin produced by the bacterium Clostridium botulinum. The toxin attacks the nervous system and can lead to life-threatening complications if not treated promptly.

Botulism is considered a medical emergency because it can cause paralysis and breathing difficulties.

Types of Botulism

There are several forms of botulism, including:

• Foodborne botulism
• Wound botulism
• Iatrogenic botulism
• Inhalation botulism
• Infant botulism

Infant botulism is the most common form in babies between 2 and 8 months old. It occurs when Clostridium botulinum spores grow in a baby's intestines and produce toxin. Honey and contaminated soil are known sources of exposure.

Symptoms of Infant Botulism

Symptoms typically begin 18 to 36 hours after exposure and may include:

• Constipation is often the first sign
• Weak or floppy movements
• Weak cry
• Drooling
• Drooping eyelids
• Difficulty feeding or sucking
• Progressive paralysis

Infant botulism often begins with constipation but is usually first recognized through feeding difficulties, a weak or altered cry, and poor head control.

If left untreated, the illness can progress to severe paralysis, breathing difficulties, and prolonged hospitalization.

Blood disorders are often misunderstood; many people think that all serious blood-related conditions are a form of cancer. This misunderstanding is particularly common when it comes to sickle cell disease. Both sickle cell disease and blood cancers affect blood cells and can lead to significant health complications, but they are fundamentally different, with distinct causes, treatment approaches, and long-term outcomes. Understanding these differences is important not only for patients and their families but also for awareness and ensuring timely medical care.

Sickle cell disease is an inherited genetic disorder that develops in a person who inherits abnormal hemoglobin genes from both parents. Hemoglobin is the protein in red blood cells responsible for carrying oxygen throughout the body. People with sickle cell disease have red blood cells that become rigid and crescent or "sickle" shaped instead of their normal round structure. These abnormal cells can block blood vessels, reduce oxygen delivery to tissues, and break down more rapidly than healthy red blood cells. As a result, patients may experience chronic anemia, episodes of severe pain, recurrent infections, organ damage, and other complications.

How Blood Cancers Differ From Sickle Cell Disease

Blood cancers are cancers that originate in the blood-forming tissues, such as the bone marrow and lymphatic system. The most common types include leukemia, lymphoma, and multiple myeloma. Unlike sickle cell disease, blood cancers are generally not inherited and are caused by DNA mutations that occur during a person's lifetime. These mutations cause abnormal blood cells to grow, crowding out healthy cells and interfering with the body's ability to fight infections, carry oxygen, or control bleeding.

The two conditions are different, but some symptoms may overlap. For instance, tiredness, weakness, recurrent infections, and anemia can occur in both sickle cell disease and certain blood cancers. However, the underlying reasons are entirely different. In sickle cell disease, symptoms arise because of abnormal hemoglobin and sickling of red blood cells. In blood cancers, symptoms result from the uncontrolled growth of malignant cells within the bone marrow or lymphatic system.

Difference in Diagnosis And Treatment

Diagnoses for both diseases differ. Sickle cell disease is usually identified through specialized blood tests that detect abnormal hemoglobin. In many cases, it can be diagnosed early in childhood. Blood cancers require a combination of blood investigations, bone marrow examinations, imaging studies, and specialized laboratory tests to establish the diagnosis and determine the specific cancer subtype.

The treatment approaches for these disorders reflect these differences. Management of sickle cell disease focuses on preventing complications, controlling symptoms, reducing pain crises, preventing infections, and improving quality of life. Certain patients may benefit from advanced therapies, including stem cell transplantation and emerging gene-based treatments.

Why Awareness Matters

Blood cancer treatment depends on the type and stage of disease and may require chemotherapy, targeted therapy, immunotherapy, stem cell transplantation, radiation therapy, or newer cellular therapies such as CAR-T cell therapy. The treatment plan is individual-based, depending on factors such as the specific cancer subtype, disease burden, patient age, pre-existing conditions, and overall health.

While medical advances are transforming outcomes for both conditions, improved screening infrastructure and programs, better care, advances in transplantation, targeted therapies and innovative cellular treatments are helping patients live longer and healthier than ever before. That said, awareness remains the first step towards better outcomes. Knowing the differences between sickle cell disease and blood cancers can help reduce confusion, support early diagnosis, and timely intervention.

(By Dr. Narendra Agrawal, Sr. Consultant – Hemato Oncology & Bone Marrow Transplant, Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), New Delhi)

GLP-1 drugs like Ozempic, Mounjaro, and Wegovy may not only aid weight loss and improve diabetes control but could also help men with obesity improve their fertility, according to new research.

Obesity is a well-established risk factor for infertility in both men and women. The findings, presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago, suggest that GLP-1 medications do not harm male hormones or fertility, even with long-term use.

Researchers from the University Hospitals Coventry and Warwickshire and Warwick Medical School in the UK found that GLP-1 drugs may improve testosterone levels and sperm quality in men with obesity-related low testosterone while addressing the underlying metabolic effects of obesity.

"This work supports a shift away from prescribing testosterone replacement in men with obesity and low testosterone and toward treating the underlying cause—excess weight and poor metabolic health—which can naturally restore hormone levels and preserve fertility," said lead researcher and endocrinologist Pratibha Natesh of Warwick Medical School.

What Did The Study Find?

Also read: Ozempic-Like Weight-Loss Drugs May Cut Breast Cancer Risk By A Third, Finds Research

The researchers analyzed published randomized controlled trials comparing GLP-1 medications with either placebo or other treatments in men aged 18 to 65 years.

The review focused primarily on changes in testosterone and other hormones involved in testicular function. Researchers also evaluated sperm quality, body weight, blood sugar levels, cholesterol, and overall metabolic health.

To minimize bias, two independent reviewers assessed the studies, with five clinical trials meeting the eligibility criteria.

Overall, the findings showed that GLP-1 drugs had no negative impact on reproductive hormones, sexual function, or sperm quality.

For instance, a 24-week study of semaglutide found improvements in sperm morphology and cholesterol levels while maintaining stable testosterone and hormone levels.

Another 16-week study of liraglutide in men with obesity-related low testosterone showed increases in testosterone and associated reproductive hormones. Participants also experienced better overall health outcomes compared with those receiving testosterone replacement therapy alone.

More Research Needed

Read More: Mayim Bialik Says Just One GLP-1 Shot Triggered ‘Nightmare’ Side Effects

Despite the encouraging findings, Natesh cautioned that the number of available studies remains small and results vary across trials. Larger, well-designed studies are needed to better understand the effects of GLP-1 drugs on male fertility.

She also emphasized that most of the reproductive benefits observed are likely indirect and that GLP-1 medications have not been evaluated as treatments for male infertility or hypogonadism.

Nevertheless, the researchers hope the findings will help patients and physicians make more informed decisions about GLP-1 medications used for weight management and diabetes treatment.

"Improving metabolic health can have positive effects far beyond weight alone," Natesh said.

What Are GLP-1 Drugs

GLP-1 receptor agonists are medications to control high blood sugar in people with type 2 diabetes.

These therapies help by:

• Increasing insulin release when blood sugar rises
• Delaying stomach emptying
• Reducing appetite
• Decreasing glucagon production
• Improving weight loss

Dr. Uthra, a diabetologist and Sr. consultant at Dr.Mohan’s Diabetes Speciality Centre, in Chennai, told HealthandMe that while GLP-1 therapies help control blood sugar, beyond this, these treatment regimens provide many more benefits.

Research shows that these medications can reduce the risk of major cardiovascular events such as heart attack and stroke.

In addition, GLP-1 therapies help in weight reduction. Obesity is also linked to diabetes and heart disease. Hence, GLP-1 therapies help to reduce weight and the risk of developing heart diseases, the expert said.